Cargando…

An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study

Allergic rhinitis (AR) is one of the common allergic diseases in clinical practice and significantly impairs the quality of life (QoL) of patients. The conventional treatments are not satisfactory because of various reasons. Tian Jiu (TJ) therapy is a characteristic external intervention of compleme...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Liang, Zhong, Linda L. D., Kun, Wai, Lam, Wai Ching, Yang, Zhen, Huang, Tao, Mu, Huaixue, Bian, Zhao-xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487095/
https://www.ncbi.nlm.nih.gov/pubmed/31097971
http://dx.doi.org/10.1155/2019/6369754
_version_ 1783414439938097152
author Dai, Liang
Zhong, Linda L. D.
Kun, Wai
Lam, Wai Ching
Yang, Zhen
Huang, Tao
Mu, Huaixue
Bian, Zhao-xiang
author_facet Dai, Liang
Zhong, Linda L. D.
Kun, Wai
Lam, Wai Ching
Yang, Zhen
Huang, Tao
Mu, Huaixue
Bian, Zhao-xiang
author_sort Dai, Liang
collection PubMed
description Allergic rhinitis (AR) is one of the common allergic diseases in clinical practice and significantly impairs the quality of life (QoL) of patients. The conventional treatments are not satisfactory because of various reasons. Tian Jiu (TJ) therapy is a characteristic external intervention of complementary and alternative medicine (CAM) and has been widely utilized in the management of AR. However, the evidences resulted from current studies were generally poor due to high risk of bias. Therefore, we conducted this rigorous designed, single-blinded, three-arm, randomized controlled study to evaluate the efficacy and safety of TJ therapy on AR. Totally 138 AR patients were enrolled. The TJ group and placebo group received 4-week treatment with either TJ or placebo patches for 2 hours each time applied to Dazhui (GV 14), bilateral Feishu (UB 13), and bilateral Shenshu (UB 23) one session per week and then underwent a 4-week follow-up. The waitlist group received no treatment during the corresponding treatment period, but would be given compensatory TJ treatment in the next 4 weeks. The primary outcome was the change of the Total Nasal Symptom Score (TNSS) after treatment. The secondary outcomes included the changes of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and rescue medication score (RMS). After treatment, the total TNSS in TJ group was significantly reduced compared with baseline, but showed no statistical meaning compared with placebo. Among the four domains of TNSS, the change of nasal obstruction exhibited statistical difference compared with placebo group. The total RQLQ score in TJ group was significantly reduced compared with both placebo and waitlist groups. The needs of rescue medications were no distinct difference between two groups. In summary, this study showed potential effectiveness of TJ therapy in improving nasal obstruction symptoms and QoL of AR patients.
format Online
Article
Text
id pubmed-6487095
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64870952019-05-16 An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study Dai, Liang Zhong, Linda L. D. Kun, Wai Lam, Wai Ching Yang, Zhen Huang, Tao Mu, Huaixue Bian, Zhao-xiang Evid Based Complement Alternat Med Research Article Allergic rhinitis (AR) is one of the common allergic diseases in clinical practice and significantly impairs the quality of life (QoL) of patients. The conventional treatments are not satisfactory because of various reasons. Tian Jiu (TJ) therapy is a characteristic external intervention of complementary and alternative medicine (CAM) and has been widely utilized in the management of AR. However, the evidences resulted from current studies were generally poor due to high risk of bias. Therefore, we conducted this rigorous designed, single-blinded, three-arm, randomized controlled study to evaluate the efficacy and safety of TJ therapy on AR. Totally 138 AR patients were enrolled. The TJ group and placebo group received 4-week treatment with either TJ or placebo patches for 2 hours each time applied to Dazhui (GV 14), bilateral Feishu (UB 13), and bilateral Shenshu (UB 23) one session per week and then underwent a 4-week follow-up. The waitlist group received no treatment during the corresponding treatment period, but would be given compensatory TJ treatment in the next 4 weeks. The primary outcome was the change of the Total Nasal Symptom Score (TNSS) after treatment. The secondary outcomes included the changes of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and rescue medication score (RMS). After treatment, the total TNSS in TJ group was significantly reduced compared with baseline, but showed no statistical meaning compared with placebo. Among the four domains of TNSS, the change of nasal obstruction exhibited statistical difference compared with placebo group. The total RQLQ score in TJ group was significantly reduced compared with both placebo and waitlist groups. The needs of rescue medications were no distinct difference between two groups. In summary, this study showed potential effectiveness of TJ therapy in improving nasal obstruction symptoms and QoL of AR patients. Hindawi 2019-04-14 /pmc/articles/PMC6487095/ /pubmed/31097971 http://dx.doi.org/10.1155/2019/6369754 Text en Copyright © 2019 Liang Dai et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dai, Liang
Zhong, Linda L. D.
Kun, Wai
Lam, Wai Ching
Yang, Zhen
Huang, Tao
Mu, Huaixue
Bian, Zhao-xiang
An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title_full An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title_fullStr An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title_full_unstemmed An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title_short An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study
title_sort external cam therapy (tian jiu) versus placebo in treatment of allergic rhinitis: a pilot single-blinded, three-arm, randomized controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487095/
https://www.ncbi.nlm.nih.gov/pubmed/31097971
http://dx.doi.org/10.1155/2019/6369754
work_keys_str_mv AT dailiang anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT zhonglindald anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT kunwai anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT lamwaiching anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT yangzhen anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT huangtao anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT muhuaixue anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT bianzhaoxiang anexternalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT dailiang externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT zhonglindald externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT kunwai externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT lamwaiching externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT yangzhen externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT huangtao externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT muhuaixue externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy
AT bianzhaoxiang externalcamtherapytianjiuversusplacebointreatmentofallergicrhinitisapilotsingleblindedthreearmrandomizedcontrolledstudy